Tweets
Among pregnant women, receipt of the BNT162b2 vaccine was associated with a 78% lower risk of incident SARS-CoV-2 infection. Cohort study tincluded 15 060 pregnant women in Israel. No adverse pregnancy outcome difference in Vax Pts https://t.co/jXUjaKIfUV
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
Biologic Therapy of Psoriasis May Prevent Psoriatic Arthritis
Another retrospective cohort study has shown that biologic treatment of psoriasis may reduce the subsequent incidence of psoriatic arthritis (PsA).
https://t.co/2YbLBsFedv https://t.co/yn47Ipu6K9
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
Novel tech Sorrento's SOFUSA system, in Phase Ib trial, etanercept given by transdermal nanotopography microneedles to deliver higher concentration of drugs to lymphatic system. An enbrel refractory pt treated & showed 34% improved DAS scores https://t.co/S79HUBT7rE
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
CDC: LA county breakthrough COVID infections: In 43,000 new COVID, 10,895, or 25.3%, occurred in fully vaccinated persons, 1,431, or 3.3%, were in partially vaccinated persons, and 30,801, or 71.4%, were in unvaccinated individuals. https://t.co/gbgaV7THch
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
European Commission has approved bimekizumab (Bimzelx) for the Treatment of Adults with Moderate to Severe Plaque Psoriasis. Bimekizumab is a dual IL-17 inhibitor (IL-17A and IL-17F). https://t.co/viRNbx2cbt
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
Most recent numbers from the CDC - The agency said 202,041,893 people had received at least one dose while 171,367,657 people are fully vaccinated as of Tuesday. https://t.co/3rp7QMt84y
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
Safety study of 97 AAV (72 GPA, 25 MPA) pts Rx with Rituxan, median 8 infusions, followed median 3.9 yrs (0.05–4.32). Serious Risks (per 100 Pt-Yrs): serious infections 7.11, cardiac events 5.0, & vascular events 2.37. No deaths related to RTX. https://t.co/WLMQoq79gd
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
Psoriasis Prevalence in adults in the United States is 3.0%, indicating that more than 7.5 million adults 20 years or older have psoriasis. Most common in non-Hispanic White individuals; prevalence has not significantly changed since 2003. https://t.co/3yrlPu1GGi
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
New download available!
Cytokine Storm Overview
https://t.co/XRlx3OJDeR https://t.co/jq9ZJVx5zH
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
A current report in Arthritis & Rheumatology examined the Nurses Health Study II data set and shows that parental smoking and passive exposure to children, can later lead to an increased risk of adult-onset incident seropositive rheumatoid arthritis (RA).
https://t.co/szl5L7DGJG https://t.co/yxoEquyLjP
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
Rheums--have a question or case for Jack Cush? Record it here and we may feature it on an upcoming podcast. Tell us your name and where you practice rheumatology.
https://t.co/wzNmOzH4VE https://t.co/QJn6Uo3lbM
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
European Commission has approved tofacitinib (Xeljanz) to treat active polyarticular juvenile idiopathic arthritis & juvenile psoriatic arthritis (PsA) > 2yrs old, not responding to DMARDs (as tablet & new oral solution (weight-based dosing) https://t.co/FyqZI0qsYa
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
